Lipoproteins at the blood brain-barrier interfaces
A webinar by Evelina Voloviceva, University Hospital of Zurich
is a PhD student in the group of , where she studies how genetic variation in apolipoprotein E (APOE) shapes the risk of Alzheimer’s disease. Although APOE4 is known as the strongest genetic risk factor, how APOE influences brain function is still not fully understood.
In this webinar, Evelina Voloviceva presents a new perspective on apolipoprotein E (apoE), moving beyond its traditional view as a single lipid transport protein. In the brain, apoE is produced by different cell types including astrocytes, pericytes, and microglia which generate distinct lipoprotein particles. Her research reveals that these particles differ in their protein and lipid composition depending on their cellular origin, and that these differences are linked to key processes in Alzheimer’s disease, such as amyloid pathology and disrupted lipid metabolism.
Event details:
- Date: 30.04.2026
- Time: 16:00
- Duration: 45 minutes (includes Q&A)
- Location: Online (link to be provided upon registration)
- Costs: Free of charge
Register today:
The Dementia Update - Virtual Series is a monthly online event designed to promote knowledge exchange among experts in neurodegenerative disorders. It brings together researchers, clinicians, caregivers and industry professionals to share the latest research, and innovations. Each 45-minute session features a presentation, offering a platform for networking, idea exchange and exploring future collaborations.
Be part of this exciting virtual session and secure your spot!